Authors’ response to commentaries on rosuvastatin for delirium and cognitive impairment in sepsis-associated acute respiratory distress syndrome

Samankaltaisia teoksia

• Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial
  Tekijä: Needham, Dale M, et al.
  Julkaistu: (2016)
• One-Year Outcomes of Rosuvastatin vs. Placebo in Sepsis-Associated Acute Respiratory Distress Syndrome: Prospective Follow-up of SAILS Randomized Trial
  Tekijä: Dinglas, Victor D., et al.
  Julkaistu: (2016)
• Association of rosuvastatin and delirium in severe sepsis with acute respiratory distress syndrome
  Tekijä: Pourafkari, Leili, et al.
  Julkaistu: (2016)
• Upper arm anthropometrics versus DXA scan in survivors of acute respiratory distress syndrome
  Tekijä: Chan, Kitty S., et al.
  Julkaistu: (2018)
• Risk Factors for Physical Impairment after Acute Lung Injury in a National, Multicenter Study
  Tekijä: Needham, Dale M., et al.
  Julkaistu: (2014)